Legal Representation
Attorney
Mark I. Feldman, Christina L. Martini, Monica L. Thompson, Keith W. Medansky, Linda Urbanik Johnson, Gina L. Durham, Amy C. Ziegler, Nicole A. Chaudhari and Daniel I. Hwang
USPTO Deadlines
Application History
23 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 13, 2009 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 12, 2009 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Feb 25, 2009 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Feb 23, 2009 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 23, 2009 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Sep 11, 2008 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Sep 11, 2008 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Sep 5, 2008 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Sep 5, 2008 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 11, 2008 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 18, 2007 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Nov 28, 2007 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Nov 13, 2007 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Nov 13, 2007 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Oct 10, 2007 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 27, 2007 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 27, 2007 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 27, 2007 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jun 12, 2007 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 30, 2007 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 30, 2007 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 29, 2007 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 13, 2007 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders, and complications associated therewith
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005